Lifestyle Strategies for Improving Diabetes Outcomes
Impact of Two Lifestyle Strategies for Improving Diabetes Related Health Outcomes in a Specialty Care Setting: A Randomized Controlled Trial
1 other identifier
interventional
200
1 country
1
Brief Summary
The objective of this study is to investigate whether a behavioral modification intervention in the form of either a 6-month supervised training program or a 6-month financial incentive weight loss program, results in improvement of diabetes outcome such as overall sugar control and lipid control.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable diabetes
Started Jul 2018
Typical duration for not_applicable diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 4, 2014
CompletedFirst Posted
Study publicly available on registry
August 7, 2014
CompletedStudy Start
First participant enrolled
July 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedFebruary 20, 2017
February 1, 2017
2.4 years
August 4, 2014
February 16, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Three months average blood glucose (A1c)
We will assess the effect of supervised training and financially incentivized weight loss on three month average blood glucose in patients with diabetes.
at 3 months and 6 months
Secondary Outcomes (3)
apo B
6 months
systolic blood pressure (SBP)
3 months and 6 months
A1c
3 months and 6 months
Other Outcomes (4)
Composite: Psychosocial outcomes are depressive symptoms, Diabetes specific quality of life
3 months and 6 months,
waist circumference
3 months and 6 months,
weight
3 months and 6 months,
- +1 more other outcomes
Study Arms (3)
Financially incentivized weight loss
ACTIVE COMPARATORParticipants can be assigned to the financially incentivized weight loss group in which they can receive 50 dollars at the end of the month if they achieve their monthly weight loss goal.
Standard of Care
PLACEBO COMPARATORParticipants can be assigned to standard of care where they receive no intervention.
Supervised Exercise
ACTIVE COMPARATORParticipants can be assigned to the supervised exercise arm which they will receive supervised professional training once a week.
Interventions
Supervised exercise intervention is training with professional trainers once a week. It will include aerobic exercise tailored to the individual participant.
Financially incentivized weight loss encourages participants to achieve a monthly goal weight reduction for a 50 dollars prize.
Eligibility Criteria
You may qualify if:
- Age 18 or older.
- Have been diagnosed with Type 2 diabetes by CDA guidelines.
- A1c \> 8.0 no more than 30 days prior to randomization and confirmed at the time of randomization.
- Overweight or obese as defined by BMI of \>25.
You may not qualify if:
- Have medical co-morbidities that limit their exercise capacity (terminal cancer, severe physical disability such as limb amputation, blindness, seizure disorder, strokes with residual deficits, arrhythmias that would limit physical activity).
- Alcohol or drug abuse that would interfere with exercise regimen.
- Cannot read or write English (with the assistance of an interpreter) or are unable to fill out logs and questionnaire.
- Inability or unwillingness of subject or legal guardian/representative to give written informed consent.
- Patients for whom an exercise program is deemed medically inadvisable.
- Patients already enrolled in a supervised training program.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tom Elliottlead
Study Sites (1)
Vancouver General Hospital
Vancouver, British Columbia, V5Z1M9, Canada
Related Publications (3)
Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010 Jan;87(1):4-14. doi: 10.1016/j.diabres.2009.10.007. Epub 2009 Nov 6.
PMID: 19896746BACKGROUNDKlein S, Sheard NF, Pi-Sunyer X, Daly A, Wylie-Rosett J, Kulkarni K, Clark NG; American Diabetes Association; North American Association for the Study of Obesity; American Society for Clinical Nutrition. Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies. A statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition. Am J Clin Nutr. 2004 Aug;80(2):257-63. doi: 10.1093/ajcn/80.2.257.
PMID: 15277143BACKGROUNDAnderson JW, Kendall CW, Jenkins DJ. Importance of weight management in type 2 diabetes: review with meta-analysis of clinical studies. J Am Coll Nutr. 2003 Oct;22(5):331-9. doi: 10.1080/07315724.2003.10719316.
PMID: 14559925BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tom Elliott, MD
BCDiabetes.Ca
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Clinical Associate Professor
Study Record Dates
First Submitted
August 4, 2014
First Posted
August 7, 2014
Study Start
July 1, 2018
Primary Completion
December 1, 2020
Study Completion
December 1, 2021
Last Updated
February 20, 2017
Record last verified: 2017-02
Data Sharing
- IPD Sharing
- Will not share
There is no plan to share IPD to other researchers except those involved in the trial